MX2007004247A - Angiopoietin-2 specific binding agents. - Google Patents
Angiopoietin-2 specific binding agents.Info
- Publication number
- MX2007004247A MX2007004247A MX2007004247A MX2007004247A MX2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A MX 2007004247 A MX2007004247 A MX 2007004247A
- Authority
- MX
- Mexico
- Prior art keywords
- angiopoietin
- specific binding
- binding agents
- antibodies
- disclosed
- Prior art date
Links
Abstract
Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62016104P | 2004-10-19 | 2004-10-19 | |
US10/982,440 US7658924B2 (en) | 2001-10-11 | 2004-11-04 | Angiopoietin-2 specific binding agents |
PCT/US2005/037911 WO2006045049A1 (en) | 2004-10-19 | 2005-10-19 | Angiopoietin-2 specific binding agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007004247A true MX2007004247A (en) | 2007-06-12 |
Family
ID=39608222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007004247A MX2007004247A (en) | 2004-10-19 | 2005-10-19 | Angiopoietin-2 specific binding agents. |
Country Status (10)
Country | Link |
---|---|
JP (2) | JP2008520188A (en) |
CN (1) | CN101495513B (en) |
BR (1) | BRPI0518209A (en) |
EA (1) | EA011866B1 (en) |
IL (1) | IL182279A0 (en) |
MA (1) | MA29015B1 (en) |
MX (1) | MX2007004247A (en) |
RU (2) | RU2404992C2 (en) |
SG (1) | SG156668A1 (en) |
ZA (1) | ZA200704020B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG156668A1 (en) * | 2004-10-19 | 2009-11-26 | Amgen Inc | Angiopoietin-2 specific binding agents |
JO3182B1 (en) * | 2009-07-29 | 2018-03-08 | Regeneron Pharma | High Affinity Human Antibodies to Human Angiopoietin-2 |
EA022546B1 (en) * | 2011-09-28 | 2016-01-29 | Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук | Method for inhibiting growth of ehrlich carcinoma in laboratory animal |
KR102225422B1 (en) * | 2011-09-30 | 2021-03-08 | 다나-파버 캔서 인스티튜트 인크. | Therapeutic peptides |
BR112014017882A2 (en) * | 2012-01-23 | 2017-06-27 | Regeneron Pharma | stabilized formulations containing anti-ang-2 antibodies |
EP2935294A4 (en) * | 2012-12-21 | 2016-08-31 | Univ California | Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity |
EP2997377B1 (en) | 2013-05-14 | 2018-07-18 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
AR100270A1 (en) * | 2014-05-19 | 2016-09-21 | Lilly Co Eli | ANTIBODIES ANG2 |
MX2017001980A (en) | 2014-08-28 | 2017-05-04 | Eisai R&D Man Co Ltd | High-purity quinoline derivative and method for manufacturing same. |
SG11201706630UA (en) | 2015-02-25 | 2017-09-28 | Eisai R&D Man Co Ltd | Method for suppressing bitterness of quinoline derivative |
AU2015384801B2 (en) | 2015-03-04 | 2022-01-06 | Eisai R&D Management Co., Ltd. | Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer |
MX2017015896A (en) | 2015-06-16 | 2018-08-09 | Eisai R&D Man Co Ltd | Anticancer agent. |
CN106512006A (en) * | 2016-07-25 | 2017-03-22 | 广州道瑞医药科技有限公司 | Application of ANGPT2 secretion inhibitor to preparation of medicine for treating hemangiomas |
CN106075448A (en) * | 2016-07-25 | 2016-11-09 | 广州道瑞医药科技有限公司 | ANGPT2 inhibitor is used for treating the application in angiomatous medicine in preparation |
CN109096368B (en) * | 2018-09-30 | 2021-07-20 | 华南理工大学 | Polypeptide with antioxidant and liver protecting activities, gene for encoding polypeptide, preparation method and application thereof |
JP7177284B2 (en) * | 2019-02-25 | 2022-11-22 | ファームアブシン・インコーポレイテッド | Anti-ANG2 antibody and use thereof |
CN112126671B (en) * | 2020-08-18 | 2021-08-31 | 中山大学附属第五医院 | Application of streptococcus agalactiae streptococcus agalactiae in treating endometriosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60003011T2 (en) * | 1999-03-26 | 2004-04-08 | Regeneron Pharmaceuticals, Inc. | MODULATING VASCER PERMABILITY BY TIE2 RECEPTOR ACTIVATORS |
US7521053B2 (en) * | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7205275B2 (en) * | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
AU2002362772B2 (en) * | 2001-10-12 | 2007-09-06 | Aquestive Therapeutics, Inc. | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
SG156668A1 (en) * | 2004-10-19 | 2009-11-26 | Amgen Inc | Angiopoietin-2 specific binding agents |
-
2005
- 2005-10-19 SG SG200907008-7A patent/SG156668A1/en unknown
- 2005-10-19 EA EA200700876A patent/EA011866B1/en not_active IP Right Cessation
- 2005-10-19 JP JP2007538066A patent/JP2008520188A/en active Pending
- 2005-10-19 RU RU2007118670/13A patent/RU2404992C2/en not_active IP Right Cessation
- 2005-10-19 MX MX2007004247A patent/MX2007004247A/en active IP Right Grant
- 2005-10-19 CN CN200580043569.5A patent/CN101495513B/en not_active Expired - Fee Related
- 2005-10-19 BR BRPI0518209-3A patent/BRPI0518209A/en not_active IP Right Cessation
-
2007
- 2007-03-28 IL IL182279A patent/IL182279A0/en unknown
- 2007-05-11 MA MA29892A patent/MA29015B1/en unknown
- 2007-05-18 ZA ZA200704020A patent/ZA200704020B/en unknown
-
2010
- 2010-08-05 RU RU2010132956/10A patent/RU2010132956A/en not_active Application Discontinuation
-
2011
- 2011-03-30 JP JP2011075243A patent/JP2011207882A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EA011866B1 (en) | 2009-06-30 |
RU2404992C2 (en) | 2010-11-27 |
RU2007118670A (en) | 2008-12-27 |
RU2010132956A (en) | 2012-02-10 |
JP2008520188A (en) | 2008-06-19 |
BRPI0518209A (en) | 2008-11-04 |
SG156668A1 (en) | 2009-11-26 |
CN101495513A (en) | 2009-07-29 |
JP2011207882A (en) | 2011-10-20 |
ZA200704020B (en) | 2008-06-25 |
IL182279A0 (en) | 2007-07-24 |
MA29015B1 (en) | 2007-11-01 |
CN101495513B (en) | 2014-08-06 |
EA200700876A1 (en) | 2007-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007004247A (en) | Angiopoietin-2 specific binding agents. | |
RS28904A (en) | Angiopoietin-2 specific binding agents | |
MY156458A (en) | Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof | |
LUC00025I2 (en) | ||
PH12016501691A1 (en) | Antibodies to matrix metalloproteinase 9 | |
SG166090A1 (en) | Il-13 binding agents | |
WO2010017103A3 (en) | Fully human anti-human nkg2d monoclonal antibodies | |
TN2011000528A1 (en) | Compositions and methods for antibodies targeting complement protein c3b | |
WO2012047583A3 (en) | Antibodies binding human collagen ii | |
EA200400526A1 (en) | AGENTS SPECIFICALLY CONNECTING WITH HUMAN ANGIOPOETIN-2 | |
MX2009006471A (en) | Engineered anti-tslp antibody. | |
WO2006029220A3 (en) | Combination therapy with anti-ctla4 and anti-4-1bb antibodies | |
WO2006116319A3 (en) | Reagents that bind ccx-ckr2 | |
WO2007076465A3 (en) | Cln248 antibody compositions and methods of use | |
TN2010000374A1 (en) | Antibodies directed to angiopoietin -1 and angiopoietin-2 and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |